|
1
|
DeSantis CE, Ma J, Sauer Goding A, Newman
LA and Jemal A: Breast cancer statistics, 2017, racial disparity in
mortality by state. CA Cancer J Clin. 67:439–448. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karimi Z, Jessri M, Houshiar-Rad A,
Mirzaei HR and Rashidkhani B: Dietary patterns and breast cancer
risk among women. Public Health Nutr. 17:1098–1106. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hart CD, Migliaccio I, Malorni L,
Guarducci C, Biganzoli L and Di Leo A: Challenges in the management
of advanced, ER-positive, HER2-negative breast cancer. Nat Rev Clin
Oncol. 12:541–552. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arnedos M, Vicier C, Loi S, Lefebvre C,
Michiels S, Bonnefoi H and Andre F: Precision medicine for
metastatic breast cancer-limitations and solutions. Nat Rev Clin
Oncol. 12:693–704. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou QM, Wang XF, Liu XJ, Zhang H, Lu YY,
Huang S and Su SB: Curcumin improves MMC-based chemotherapy by
simultaneously sensitising cancer cells to MMC and reducing
MMC-associated side-effects. Eur J Cancer. 47:2240–2247. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nagaraju GP, Aliya S, Zafar SF, Basha R,
Diaz R and El-Rayes BF: The impact of curcumin on breast cancer.
Integr Biol (Camb). 4:996–1007. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quispe-Soto ET and Calaf GM: Effect of
curcumin and paclitaxel on breast carcinogenesis. Int J Oncol.
49:2569–2577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee JY, Lee YM, Chang GC, Yu SL, Hsieh WY,
Chen JJ, Chen HW and Yang PC: Curcumin induces EGFR degradation in
lung adenocarcinoma and modulates p38 activation in intestine: The
versatile adjuvant for gefitinib therapy. PLoS One. 6:e237562011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoshida K, Toden S, Ravindranathan P, Han
H and Goel A: Curcumin sensitizes pancreatic cancer cells to
gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1
expression. Carcinogenesis. 38:1036–1046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gallardo M and Calaf GM: Curcumin inhibits
invasive capabilities through epithelial mesenchymal transition in
breast cancer cell lines. Int J Oncol. 49:1019–1027. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gallardo M and Calaf GM: Curcumin and
epithelial-mesenchymal transition in breast cancer cells
transformed by low doses of radiation and estrogen. Int J Oncol.
48:2534–2542. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khalil OAK, de Faria Oliveir OMM, Vellosa
JCR, Quadros AU, Dalposso LM, Karam TK, Mainardes RM and Khalil NM:
Curcumin antifungal and antioxidant activities are increased in the
presence of ascorbic acid. Food Chem. 133:1001–1005. 2012.
View Article : Google Scholar
|
|
13
|
Perrone D, Ardito F, Giannatempo G,
Dioguardi M, Troiano G, Lo Russo L, Lillo DE A, Laino L and Lo
Muzio L: Biological and therapeutic activities, and anticancer
properties of curcumin. Exp Ther Med. 10:1615–1623. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
El-Houseini ME, El-Agoza IA, Sakr MM and
El-Malky GM: NNovel protective role of curcumin and taurine
combination against experimental hepatocarcinogenesis. Exp Ther
Med. 13:29–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park MJ, Kim EH, Park IC, Lee HC, Woo SH,
Lee JY, Hong YJ, Rhee CH, Choi SH, Shim BS, et al: Curcumin
inhibits cell cycle progression of immortalized human umbilical
vein endothelial (ECV304) cells by up-regulating cyclin-dependent
kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53. Int J Oncol.
21:379–383. 2002.PubMed/NCBI
|
|
16
|
Kunnumakkara AB, Guha S, Krishnan S,
Diagaradjane P, Gelovani J and Aggarwal BB: Curcumin potentiates
antitumor activity of gemcitabine in an orthotopic model of
pancreatic cancer through suppression of proliferation,
angiogenesis, and inhibition of nuclear factor-kappaB-regulated
gene products. Cancer Res. 67:3853–3861. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hussain AR, Al-Rasheed M, Manogaran PS,
Al-Hussein KA, Platanias LC, Al Kuraya K and Uddin S: Curcumin
induces apoptosis via inhibition of PI3′-kinase/AKT pathway in
acute T cell leukemias. Apoptosis. 11:245–254. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park C, Kim GY, Kim GD, Choi BT, Park YM
and Choi YH: Induction of G2/M arrest and inhibition of
cyclooxygenase-2 activity by curcumin in human bladder cancer T24
cells. Oncol Rep. 15:1225–1231. 2006.PubMed/NCBI
|
|
19
|
Yang SX, Polley E and Lipkowitz S: New
insights on PI3K/AKT pathway alterations and clinical outcomes in
breast cancer. Cancer Treat Rev. 45:87–96. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abraham J: PI3K/AKT/mTOR pathway
inhibitors: The ideal combination partners for breast cancer
therapies? Expert Rev Anticancer Ther. 15:51–68. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Steelman LS, Martelli AM, Cocco L, Libra
M, Nicoletti F, Abrams SL and McCubrey JA: The therapeutic
potential of mTOR inhibitors in breast cancer. Br J Clin Pharmacol.
82:1189–1212. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Donia M, Mangano K, Amoroso A, Mazzarino
MC, Imbesi R, Castrogiovanni P, Coco M, Meroni P and Nicoletti F:
Treatment with rapamycin ameliorates clinical and histological
signs of protracted relapsing experimental allergic
encephalomyelitis in Dark Agouti rats and induces expansion of
peripheral CD4+CD25+Foxp3+ regulatory T cells. J Autoimmun.
33:135–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oaks Z, Winans T, Huang N, Banki K and
Perl A: Activation of the mechanistic target of rapamycin in SLE:
Explosion of evidence in the last five years. Curr Rheumatol Rep.
18:732016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nicoletti F, Fagone P, Meroni P, McCubrey
J and Bendtzen K: mTOR as a multifunctional therapeutic target in
HIV infection. Drug Discov Today. 16:715–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Donia M, McCubrey JA, Bendtzen K and
Nicoletti F: Potential use of rapamycin in HIV infection. Br J Clin
Pharmacol. 70:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nicoletti F, Lapenta C, Donati S, Spada M,
Ranazzi A, Cacopardo B, Mangano K, Belardelli F, Perno C and Aquaro
S: Inhibition of human immunodeficiency virus (HIV-1) infection in
human peripheral blood leucocytes-SCID reconstituted mice by
rapamycin. Clin Exp Immunol. 155:28–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rajamanickam V, Zhu H, Feng C, Chen X,
Zheng H, Xu X, Zhang Q, Zou P, He G, Dai X, et al: Novel allylated
monocarbonyl analogs of curcumin induce mitotic arrest and
apoptosis by reactive oxygen species-mediated endoplasmic reticulum
stress and inhibition of STAT3. Oncotarget. 8:101112–101129. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deck LM, Hunsaker LA, Vander Jagt TA,
Whalen LJ, Royer RE and Vander Jagt DL: Activation of anti-oxidant
Nrf2 signaling by enone analogues of curcumin. Eur J Med Chem.
143:854–865. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen S, Nimick M, Cridge AG, Hawkins BC
and Rosengren RJ: Anticancer potential of novel curcumin analogs
towards castrate-resistant prostate cancer. Int J Oncol.
52:579–588. 2018.PubMed/NCBI
|
|
30
|
Pan Y, Liu G, Xiao J, Su B, Zhou F and Wei
Y: A novel curcuminoid exhibits enhanced antitumor activity in
nasopharyngeal carcinoma. Int J Oncol. 48:2175–2183. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang LC, Hsieh MT, Yang JS, Lu CC, Tsai
FJ, Tsao JW, Chiu YJ, Kuo SC and Lee KH: Effect of
bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell
cycle arrest, apoptotic and autophagic pathway in triple-negative
breast adenocarcinoma MDA-MB-231 cells: An in vitro study. Int J
Oncol. 52:67–76. 2018.PubMed/NCBI
|
|
32
|
Taurin S, Nimick M, Larsen L and Rosengren
RJ: A novel curcumin derivative increases the cytotoxicity of
raloxifene in estrogen receptor-negative breast cancer cell lines.
Int J Oncol. 48:385–398. 2016. View Article : Google Scholar : PubMed/NCBI
|
